Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inGenetics

ASGCT 2026: Victoria Gray Roadshow Returns to Boston

May 13, 2026
Continue Reading
asgct-2026:-victoria-gray-roadshow-returns-to-boston
Posted inBiotechnology

Groundbreaking Heart Study Promises to Save Lives and Cut Unnecessary Implants

May 13, 2026
Continue Reading
groundbreaking-heart-study-promises-to-save-lives-and-cut-unnecessary-implants
Posted inBiotechnology

APOE2 Gene Variant Promotes Neuronal DNA Repair and Enhances Resistance to Aging

May 13, 2026
Continue Reading
apoe2-gene-variant-promotes-neuronal-dna-repair-and-enhances-resistance-to-aging
Posted inBiotechnology

NAD(P)H Dehydrogenase Diversity Drives Clofazimine Resistance

May 13, 2026
Continue Reading
nad(p)h-dehydrogenase-diversity-drives-clofazimine-resistance
Posted inBiotechnology

Closed-Loop Stimulation Enhances Children’s Attention Shifting

May 13, 2026
Continue Reading
closed-loop-stimulation-enhances-children’s-attention-shifting
Posted inBiotechnology

Enhanced Cancer Drug Targeting and Efficacy Through Molecular Grappling Hooks

May 13, 2026
Continue Reading
enhanced-cancer-drug-targeting-and-efficacy-through-molecular-grappling-hooks
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

aavs-in-focus:-practical-approaches-to-capsid-analytics-and-plasmid-dna-control
Posted inGenetics

AAVs in Focus: Practical Approaches to Capsid Analytics and Plasmid DNA Control

May 12, 2026
Adeno-associated viruses (AAVs) continue to be a foundational platform for gene therapies, with rapid advances in vector design, analytics, and…
Read More
brain-histamine-map-links-genetic-factors-to-mental-health-and-psychiatric-disorders
Posted inGenetics

Brain Histamine Map Links Genetic Factors to Mental Health and Psychiatric Disorders

May 12, 2026
Credit: Photo by Robina Weermeijer on Unsplash A study headed by researchers at King’s College London and the University of…
Read More
acute-myeloid-leukemia-therapy-improved-by-crispr-stem-cell-transplant
Posted inGenetics

Acute Myeloid Leukemia Therapy Improved by CRISPR Stem Cell Transplant

May 12, 2026
A new study led by WashU Medicine researchers shows that, for blood cancer patients, a genetically engineered stem cell transplant…
Read More
kyverna-begins-rolling-submission-for-autoimmune-car-t-as-fda-requests-more-natural-history-analysis
Posted inBiotechnology

Kyverna begins rolling submission for autoimmune CAR-T as FDA requests more natural history analysis

May 12, 2026
Kyverna Therapeutics has officially started a rolling Biologics License Application submission to the FDA for miv-cel, keeping the candidate on…
Read More
alphabet’s-ai-biotech-isomorphic-labs-bags-$2.1b-series-b-to-fuel-next-gen-drug-design-model
Posted inBiotechnology

Alphabet’s AI biotech Isomorphic Labs bags $2.1B series B to fuel next-gen drug design model

May 12, 2026
If any proof was needed that big money is still available for AI drug development, look no further than the…
Read More
boehringer-furthers-inflammatory-expansion-with-e407m-biobucks-bet-on-immunitas-asset
Posted inBiotechnology

Boehringer furthers inflammatory expansion with €407M biobucks bet on Immunitas asset

May 12, 2026
Boehringer Ingelheim has put up 407.5 million euros ($478 million) in biobucks to secure global rights to a first‑in‑class antibody Immunitas…
Read More
astrazeneca’s-$800m-bet-undermined-by-immunogenicity-in-phase-3
Posted inBiotechnology

AstraZeneca’s $800M bet undermined by immunogenicity in phase 3

May 12, 2026
Immunogenicity dragged on the efficacy of AstraZeneca’s rare endocrine disorder prospect in a phase 3 trial, causing the $800 million molecule’s…
Read More
charles-river-debuts-ai-diagnostic-tool-to-cut-down-pathology-timelines
Posted inMedical Technology

Charles River debuts AI diagnostic tool to cut down pathology timelines

May 12, 2026
Charles River is rolling out an artificial intelligence-backed digital pathology platform with a goal of trimming at least one week…
Read More
bayer-scraps-protein-therapy-for-hypertension-from-phase-1,-along-with-neuropathic-pain-drug
Posted inBiotechnology

Bayer scraps protein therapy for hypertension from phase 1, along with neuropathic pain drug

May 12, 2026
Bayer has removed a protein therapeutic for hypertension and a treatment for diabetic neuropathic pain from its phase 1 pipeline.…
Read More
roche-nabs-european-approval-for-second-eli-lilly-partnered-alzheimer’s-test
Posted inMedical Technology

Roche nabs European approval for second Eli Lilly-partnered Alzheimer’s test

May 12, 2026
Roche has grabbed a European CE mark for its second Alzheimer’s test that can both confirm the disease and help…
Read More

Posts pagination

Previous page 1 … 4 5 6 7 8 … 1,822 Next page
You May Have Missed
humacyte-cuts-spending,-staff-as-it-seeks-to-boost-sluggish-sales-for-its-off-the-shelf-artery-implant
Posted inMedical Technology

Humacyte cuts spending, staff as it seeks to boost sluggish sales for its off-the-shelf artery implant

medtronic-to-shutter-santa-rosa-plant-as-it-restructures-cardiovascular-unit
Posted inMedical Technology

Medtronic to shutter Santa Rosa plant as it restructures cardiovascular unit

astrazeneca-pens-agentic-ai-licensing-deal-with-owkin
Posted inMedical Technology

AstraZeneca pens agentic AI licensing deal with Owkin

charles-river-debuts-ai-diagnostic-tool-to-cut-down-pathology-timelines
Posted inMedical Technology

Charles River debuts AI diagnostic tool to cut down pathology timelines

Privacy Policy    Terms

Scroll to Top